1. Abdel Megeid, Azza K, Refeat, Miral M, Ashaat, Engy A, El Ruby, Mona O, Amr, Khalda S. 2022. Correlating SFTPC gene variants to interstitial lung disease in Egyptian children. In Journal, genetic engineering & biotechnology, 20, 117. doi:10.1186/s43141-022-00399-0. https://pubmed.ncbi.nlm.nih.gov/35939165/
2. Abdel Megeid, Azza K, Refeat, Miral M, Ashaat, Engy A, El Ruby, Mona O, Amr, Khalda S. 2022. Correction: Correlating SFTPC gene variants to interstitial lung disease in Egyptian children. In Journal, genetic engineering & biotechnology, 20, 137. doi:10.1186/s43141-022-00420-6. https://pubmed.ncbi.nlm.nih.gov/36129639/
3. Alysandratos, Konstantinos-Dionysios, Russo, Scott J, Petcherski, Anton, Beers, Michael F, Kotton, Darrell N. . Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease. In Cell reports, 36, 109636. doi:10.1016/j.celrep.2021.109636. https://pubmed.ncbi.nlm.nih.gov/34469722/
4. Zhang, Qiongyin, An, Ning, Liu, Yang, Pu, Qiang, Zhu, Wen. 2024. Alveolar type 2 cells marker gene SFTPC inhibits epithelial-to-mesenchymal transition by upregulating SOX7 and suppressing WNT/β-catenin pathway in non-small cell lung cancer. In Frontiers in oncology, 14, 1448379. doi:10.3389/fonc.2024.1448379. https://pubmed.ncbi.nlm.nih.gov/39346732/
5. Cooney, Ashley L, Wambach, Jennifer A, Sinn, Patrick L, McCray, Paul B. 2022. Gene Therapy Potential for Genetic Disorders of Surfactant Dysfunction. In Frontiers in genome editing, 3, 785829. doi:10.3389/fgeed.2021.785829. https://pubmed.ncbi.nlm.nih.gov/35098209/
智鼠故事 
